Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amine oxidase copper containing 4, pseudogene (AOC4P) is a long non-coding RNA (lncRNA) transcribed from a pseudogene locus related to the amine oxidase copper containing (AOC) family[2][4]. Unlike functional amine oxidases, AOC4P does **not** encode an active enzyme or receptor protein; instead, it acts as a regulatory lncRNA implicated in tumor biology[2][4]. Experimental data demonstrate that AOC4P is downregulated in various cancers, including hepatocellular carcinoma and epithelial ovarian cancer, and functions as a tumor suppressor primarily by modulating the epithelial-mesenchymal transition (EMT), reducing cancer cell proliferation, invasion, and metastasis in vitro and in vivo[2][4]. Loss of AOC4P expression correlates with poor prognosis. No evidence supports its role as a classic druggable target (enzyme, receptor, transporter, etc.), and it is best characterized as a regulatory RNA molecule affecting gene expression and cellular phenotype rather than a direct protein target for therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amine oxidase copper containing 4, pseudogene (AOC4P).